Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 751–776 of 776 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00401401	Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer	terminated	Phase 1 / Phase 2	30	GenmabINDUSTRY	5	Dec 23, 2011	clinicaltrials
NCT00805012	Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)	terminated	Phase 2	96	Seoul National University HospitalOTHER	1	Jul 26, 2011	clinicaltrials